PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SAABY vs. NOVO-B.CO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SAABY and NOVO-B.CO is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.1

Performance

SAABY vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Saab AB (publ) (SAABY) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%500.00%600.00%NovemberDecember2025FebruaryMarchApril
569.36%
27.18%
SAABY
NOVO-B.CO

Key characteristics

Sharpe Ratio

SAABY:

2.11

NOVO-B.CO:

-1.20

Sortino Ratio

SAABY:

2.68

NOVO-B.CO:

-1.78

Omega Ratio

SAABY:

1.38

NOVO-B.CO:

0.77

Calmar Ratio

SAABY:

4.26

NOVO-B.CO:

-0.84

Martin Ratio

SAABY:

7.44

NOVO-B.CO:

-1.76

Ulcer Index

SAABY:

15.98%

NOVO-B.CO:

28.68%

Daily Std Dev

SAABY:

56.42%

NOVO-B.CO:

41.86%

Max Drawdown

SAABY:

-34.43%

NOVO-B.CO:

-64.64%

Current Drawdown

SAABY:

0.00%

NOVO-B.CO:

-58.18%

Fundamentals

Market Cap

SAABY:

$24.13B

NOVO-B.CO:

DKK 1.87T

EPS

SAABY:

$0.39

NOVO-B.CO:

DKK 22.62

PE Ratio

SAABY:

58.62

NOVO-B.CO:

18.62

PEG Ratio

SAABY:

1.93

NOVO-B.CO:

0.95

PS Ratio

SAABY:

0.38

NOVO-B.CO:

6.44

PB Ratio

SAABY:

6.86

NOVO-B.CO:

13.03

Total Revenue (TTM)

SAABY:

$49.57B

NOVO-B.CO:

DKK 225.05B

Gross Profit (TTM)

SAABY:

$10.58B

NOVO-B.CO:

DKK 190.45B

EBITDA (TTM)

SAABY:

$5.20B

NOVO-B.CO:

DKK 73.25B

Returns By Period

In the year-to-date period, SAABY achieves a 118.75% return, which is significantly higher than NOVO-B.CO's -31.39% return.


SAABY

YTD

118.75%

1M

19.34%

6M

121.07%

1Y

122.97%

5Y*

N/A

10Y*

N/A

NOVO-B.CO

YTD

-31.39%

1M

-21.60%

6M

-46.94%

1Y

-50.16%

5Y*

16.32%

10Y*

10.22%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SAABY vs. NOVO-B.CO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SAABY
The Risk-Adjusted Performance Rank of SAABY is 9595
Overall Rank
The Sharpe Ratio Rank of SAABY is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of SAABY is 9393
Sortino Ratio Rank
The Omega Ratio Rank of SAABY is 9393
Omega Ratio Rank
The Calmar Ratio Rank of SAABY is 9999
Calmar Ratio Rank
The Martin Ratio Rank of SAABY is 9292
Martin Ratio Rank

NOVO-B.CO
The Risk-Adjusted Performance Rank of NOVO-B.CO is 44
Overall Rank
The Sharpe Ratio Rank of NOVO-B.CO is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of NOVO-B.CO is 44
Sortino Ratio Rank
The Omega Ratio Rank of NOVO-B.CO is 55
Omega Ratio Rank
The Calmar Ratio Rank of NOVO-B.CO is 55
Calmar Ratio Rank
The Martin Ratio Rank of NOVO-B.CO is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SAABY vs. NOVO-B.CO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Saab AB (publ) (SAABY) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SAABY, currently valued at 2.16, compared to the broader market-2.00-1.000.001.002.003.00
SAABY: 2.16
NOVO-B.CO: -1.17
The chart of Sortino ratio for SAABY, currently valued at 2.72, compared to the broader market-6.00-4.00-2.000.002.004.00
SAABY: 2.72
NOVO-B.CO: -1.72
The chart of Omega ratio for SAABY, currently valued at 1.40, compared to the broader market0.501.001.502.00
SAABY: 1.40
NOVO-B.CO: 0.77
The chart of Calmar ratio for SAABY, currently valued at 4.34, compared to the broader market0.001.002.003.004.00
SAABY: 4.34
NOVO-B.CO: -0.82
The chart of Martin ratio for SAABY, currently valued at 7.45, compared to the broader market-5.000.005.0010.0015.0020.00
SAABY: 7.45
NOVO-B.CO: -1.65

The current SAABY Sharpe Ratio is 2.11, which is higher than the NOVO-B.CO Sharpe Ratio of -1.20. The chart below compares the historical Sharpe Ratios of SAABY and NOVO-B.CO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00NovemberDecember2025FebruaryMarchApril
2.16
-1.17
SAABY
NOVO-B.CO

Dividends

SAABY vs. NOVO-B.CO - Dividend Comparison

SAABY's dividend yield for the trailing twelve months is around 0.17%, less than NOVO-B.CO's 2.71% yield.


TTM20242023202220212020201920182017201620152014
SAABY
Saab AB (publ)
0.17%0.72%0.85%1.33%2.22%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NOVO-B.CO
Novo Nordisk A/S
2.71%1.59%1.01%1.19%1.27%2.02%2.11%2.64%2.27%3.69%1.25%1.73%

Drawdowns

SAABY vs. NOVO-B.CO - Drawdown Comparison

The maximum SAABY drawdown since its inception was -34.43%, smaller than the maximum NOVO-B.CO drawdown of -64.64%. Use the drawdown chart below to compare losses from any high point for SAABY and NOVO-B.CO. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril0
-55.56%
SAABY
NOVO-B.CO

Volatility

SAABY vs. NOVO-B.CO - Volatility Comparison

Saab AB (publ) (SAABY) has a higher volatility of 18.78% compared to Novo Nordisk A/S (NOVO-B.CO) at 13.33%. This indicates that SAABY's price experiences larger fluctuations and is considered to be riskier than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
18.78%
13.33%
SAABY
NOVO-B.CO

Financials

SAABY vs. NOVO-B.CO - Financials Comparison

This section allows you to compare key financial metrics between Saab AB (publ) and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. SAABY values in USD, NOVO-B.CO values in DKK
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab